Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet

- Pain
- Completed

Study Title: A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet

Teva Identifier: C33237/1106

ClinicalTrials.gov Identifier: NCT01758978

Study Status: Completed

Trial Condition(s): Pain

Interventions: Drug: a 60 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 30-mg tablets (Treatment A) or one 60-mg tablet (Treatment B).

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 18 Years to 45 Years

Trial Duration: 12/01/2012 - 01/01/2013

Phase: Phase 1

Study Type

Interventional